CSPC Pharmaceutical Group... (CSPCY)

PNK: CSPCY · Real-Time Price · USD

3.13

0.08 (2.79%)

At close: May 02, 2025, 3:52 PM

CSPC Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	47.12B	37.9B	37.96B	46.26B	55.24B	48.19B	49.67B	47.72B	44.61B	40.19B	38.98B	35.61B	28.06B	19.76B	18.85B	17.86B	16.47B	15.08B	13.7B	12.79B	12.33B	11.87B	11.41B	10.69B	10.31B
Cost of Revenue	13.5B	11.09B	11.1B	13.27B	15.12B	12.9B	12.52B	11.67B	10.99B	10.18B	10.52B	10.19B	8.61B	6.28B	6.29B	6.27B	5.98B	5.7B	5.41B	5.33B	5.41B	5.49B	5.57B	5.36B	5.3B
Gross Profit	33.62B	26.81B	26.86B	32.99B	40.11B	35.28B	37.16B	36.05B	33.62B	30.01B	28.46B	25.41B	19.45B	13.48B	12.55B	11.59B	10.49B	9.39B	8.28B	7.46B	6.92B	6.38B	5.84B	5.33B	5.01B
Operating Income	10.98B	8.8B	8.64B	10.28B	12.16B	10.64B	11.1B	10.86B	9.85B	8.55B	7.83B	7.26B	5.83B	4.23B	4.09B	3.96B	3.67B	3.39B	3.1B	2.86B	2.73B	2.6B	2.47B	2.24B	2.09B
Interest Income	273.3M	273.3M	283.08M	384.56M	374.41M	374.41M	322.48M	308.39M	206.58M	116.57M	29.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	11.29B	9.05B	9.21B	11.11B	13.04B	11.48B	12.05B	12.19B	11.57B	9.69B	8.42B	7.45B	5.93B	4.22B	4.05B	3.88B	3.61B	3.35B	3.08B	2.85B	2.71B	2.58B	2.45B	2.21B	2.06B
Net Income	8.93B	7.16B	7.4B	8.92B	10.46B	9.21B	9.81B	10.01B	9.48B	7.85B	6.77B	6.02B	4.77B	3.4B	3.26B	3.12B	2.9B	2.69B	2.47B	2.28B	2.17B	2.06B	1.95B	1.77B	1.65B
Selling & General & Admin	15.34B	12.34B	12.96B	16.68B	20.84B	18.43B	19.98B	19.41B	18.59B	17.03B	16.76B	15.08B	11.46B	7.91B	7.33B	6.67B	5.95B	5.23B	4.5B	4.03B	3.72B	3.41B	3.1B	2.83B	2.67B
Research & Development	7.68B	6.02B	5.62B	6.19B	7.1B	6.22B	6.08B	5.78B	5.18B	4.43B	3.87B	3.17B	2.34B	1.6B	1.45B	1.2B	852.1M	504.48M	156.87M	77.53M	77.53M	77.53M	77.53M	n/a	n/a
Other Expenses	348.99M	363.56M	688.54M	551.6M	341.17M	326.6M	n/a	n/a	n/a	n/a	n/a	-2.83B	-4.95B	-7.07B	-6.36B	-6.36B	-5.1B	-3.85B	-2.59B	-2.59B	-2.38B	-2.17B	-1.96B	-2.47B	-2.34B
Operating Expenses	23.01B	18.36B	18.58B	22.92B	27.95B	24.65B	26.06B	25.19B	23.78B	21.46B	20.63B	10.75B	4.18B	-2.23B	-2.26B	-1.49B	-1.3B	-1.11B	-924.51M	-335.92M	-434.8M	-533.68M	-632.57M	356.03M	332.02M
Interest Expense	20.62M	24.49M	31.27M	35.13M	32.33M	28.45M	19.25M	16.87M	19.51M	19.91M	43.37M	45.35M	58.43M	46.56M	57.68M	57.68M	44.01M	30.35M	16.69M	5.78M	9.55M	13.32M	17.1M	39.8M	42.26M
Selling & Marketing Expenses	11.23B	8.63B	8.67B	6.54B	4.13B	1.95B	n/a	n/a	n/a	n/a	n/a	3.97B	5.58B	7.19B	6.62B	5.97B	5.28B	4.58B	3.89B	3.46B	3.17B	2.88B	2.59B	2.35B	2.2B
Cost & Expenses	36.51B	29.45B	29.68B	36.2B	43.07B	37.55B	38.57B	36.86B	34.76B	31.64B	31.15B	23.74B	17.63B	10.94B	10.19B	10.94B	9.82B	8.7B	7.58B	8.09B	7.76B	7.44B	7.11B	8.46B	8.21B
Income Tax Expense	2.08B	1.6B	1.57B	1.95B	2.37B	2.09B	2.11B	2.08B	1.97B	1.8B	1.64B	1.46B	1.15B	827.11M	795.58M	754.28M	705.75M	657.23M	608.7M	567.89M	541.61M	515.34M	489.06M	441.15M	414.8M
Shares Outstanding (Basic)	2.96B	2.96B	n/a	2.97B	2.98B	2.98B	2.98B	2.99B	2.99B	2.99B	2.99B	2.99B	2.99B	2.99B	3B	3B	3B	2.94B	2.91B	2.91B	2.92B	2.9B	2.88B	2.87B	2.88B
Shares Outstanding (Diluted)	2.96B	2.96B	n/a	2.97B	2.98B	2.98B	2.98B	2.99B	2.99B	2.99B	2.99B	2.99B	2.99B	2.99B	3B	3B	3B	3B	2.91B	2.92B	2.92B	2.92B	2.88B	2.88B	2.88B
EPS (Basic)	3.16	2.48	2.56	3.60	3.52	3.08	3.32	3.36	3.16	2.60	2.24	2.00	1.60	1.12	1.08	1.04	1.00	0.92	0.84	0.80	0.76	0.72	0.68	0.60	0.56
EPS (Diluted)	3.16	2.48	2.56	3.60	3.52	3.08	3.32	3.36	3.16	2.60	2.24	2.00	1.60	1.12	1.08	1.04	1.00	0.92	0.84	0.80	0.76	0.72	0.68	0.60	0.56
EBITDA	12.1B	9.41B	9.23B	11.37B	13.78B	12.21B	12.63B	12.45B	11.34B	9.92B	9.04B	9.41B	9.11B	7.29B	7.08B	6.94B	6.37B	6.07B	4.78B	4.55B	3.29B	3.14B	3.65B	3.41B	4.06B
EBIT	7.67B	3.7B	3.9B	5.86B	7.83B	7.83B	9.55B	11.06B	9.99B	8.71B	7.82B	7.03B	6.78B	4.2B	4.04B	4.04B	3.51B	3.51B	2.34B	2.34B	1.24B	1.24B	1.67B	1.67B	2.17B
Depreciation & Amortization	1.72B	1.21B	1.19B	1.69B	1.61B	1.58B	1.54B	1.52B	1.42B	1.3B	1.21B	801.5M	571.18M	344.78M	335.69M	351.49M	337.36M	323.23M	309.1M	303.62M	285.5M	267.38M	249.26M	521.4M	516.54M